MYO
Myomo, Inc.
MYO lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
MYO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Under pressure | |
| Unavailable |
MYO's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
MYO PE Valuation
MYO has no meaningful PE right now: it lost money over the past year.
MYO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect MYO's losses to shrink, with revenue growing.
MYO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.35 | -$0.07 |
| Q2 2026 | -$0.34 | -$0.12 |
| Q1 2026 | -$0.36 | -$0.22 |
| Q4 2025 | -$0.37 | -$0.21 |
| Q3 2025 | -$0.28 | -$0.05 |
| Q2 2025 | -$0.22 | +$0.04 |
| Q1 2025 | -$0.14 | +$0.13 |
| Q4 2024 | -$0.16 | +$0.12 |
MYO is still losing money, but far less than before: $0.35 per share over the past year, against $19.35 at its worst in late 2019.
MYO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $12.3M | +22% |
| Q2 2026 | $11.7M | +21% |
| Q1 2026 | $10.1M | +2.9% |
| Q4 2025 | $11.4M | -5.9% |
| Q3 2025 | $10.1M | +9.6% |
| Q2 2025 | $9.7M | +28% |
| Q1 2025 | $9.8M | +162% |
| Q4 2024 | $12.1M | +154% |
MYO's revenue is growing: $12M last quarter, up 22% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -14% | +21 points |
| Q2 2026 | -19% | +28 points |
| Q1 2026 | -31% | +4.6 points |
| Q4 2025 | -24% | -22 points |
| Q3 2025 | -35% | -25 points |
| Q2 2025 | -48% | -33 points |
| Q1 2025 | -36% | +68 points |
| Q4 2024 | -2% | +49 points |
MYO's operating margin was −14% last quarter, up 21 points from the same quarter a year ago.
MYO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.4M | +$1.5M |
| Q2 2026 | -$2M | +$8.1M |
| Q1 2026 | -$2.5M | +$822.4K |
| Q4 2025 | $98.1K | -96% |
| Q3 2025 | -$2.9M | -$1.1M |
| Q2 2025 | -$10.1M | -$8.1M |
| Q1 2025 | -$3.3M | -$42.2K |
| Q4 2024 | $2.5M | +$4.9M |
MYO has burned cash in almost every quarter: −$6M over the past year, against −$14M the year before.
MYO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2% | +873K shares |
| 1 year | +3.3% | +1.4M shares |
| 3 years | +24% | +8.3M shares |
| 5 years | +673% | +37.9M shares |
| Available history | +7768% | +43M shares |
MYO has 44M diluted shares, up 3.3% from a year ago.
MYO Net Leverage
MYO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MYO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.9 | Neutral |
| Stochastic | 20.7 | Neutral |
MYO's weekly RSI is 48 (neutral) and its Stochastic is 21 (neutral).
MYO PE vs Healthcare Sector
MYO has no meaningful PE right now: it lost money over the past year.
MYO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.34 | 9.7% below |
| 20 week MA | $1.32 | 8.3% below |
| 50 week MA | $1.08 | 12% above |
| 100 week MA | $2.14 | 43% below |
| 200 week MA | $2.36 | 49% below |
MYO's trend is mixed: it's above one of its five weekly moving averages, and 49% below its 200-week average.
MYO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.08 | $6.94 | -24% |
| 2021 | $6.94 | $7.90 | +14% |
| 2022 | $7.90 | $0.44 | -94% |
| 2023 | $0.44 | $5.01 | +1039% |
| 2024 | $5.01 | $6.37 | +27% |
| 2025 | $6.37 | $1.02 | -84% |
| 2026 YTD | $1.02 | $1.21 | +19% |
MYO's yearly returns have swung widely, from +1039% in 2023 to −94% in 2022. It's up 19% so far in 2026.